Seelos Therapeutics, Inc. Common Stock
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SEEL Smart Score
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Show Less
Recent trades of SEEL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SEEL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to SEEL
Recent picks made for SEEL stock on CNBC
ETFs with the largest estimated holdings in SEEL
Flights by private jets registered to SEEL